Vivifrail multicomponent exercise program
BehavioralIndividualized multicomponent home-based training (strength/power, balance, gait, and flexibility) prescribed according to the participant's Vivifrail functional profile.
NCT Number: NCT07731529
This randomized clinical trial investigates the effects of a home-based multicomponent exercise program (Vivifrail) on physical function, muscle morphology, and cognition in community-dwelling adults aged 90 years and older. Participants are randomized into three groups: Vivifrail at least twice a week, Vivifrail at least three times a week, or a control group. Outcomes are assessed at baseline, 12 weeks, and 24 weeks. The primary outcome is physical function measured by the Short Physical Performance Battery (SPPB).
Trial opening soon.
Get Notified90 year and older
All sexes
Interventional
Not applicable
Escola de Educação Física, Fisioterapia e Dança (ESEFID/UFRGS) - and participants' homes, Porto Alegre, Rio Grande do Sul, Brazil
This is a three-arm, parallel-group randomized controlled trial evaluating a home-based multicomponent exercise program based on the Vivifrail protocol in community-dwelling nonagenarians (aged 90 years or older). A total of 54 participants (18 per group) will be randomly allocated to one of three groups: G1, performing the Vivifrail program at least twice a week; G2, performing it at least three times a week; or a control group (GC) maintaining usual activities.
Randomization will be performed using Randomizer software (www.randomizer.org) by an independent researcher not involved in the assessments. Allocation is stratified by sex and by baseline functional level, defined by collapsing the six Vivifrail functional categories into two groups (lower function: Types A, B, and B+; higher function: Types C, C+, and D), to ensure balanced distribution of baseline physical function across the three groups. Each participant is still assigned the individualized Vivifrail training passport corresponding to their specific functional category. Given the autonomous, home-based nature of the intervention, participants and interventionists cannot be blinded; however, outcome assessors remain blinded to group allocation throughout the study.
Assessments occur at three timepoints: baseline (T0), 12 weeks (T1), and 24 weeks (T2). The 24-week intervention is individualized according to each participant's functional profile, determined by the Short Physical Performance Battery (SPPB) and the corresponding Vivifrail training passport.
The primary outcome is physical function measured by the total SPPB score (0-12). Secondary outcomes include mobility (Timed Up and Go and cognitive dual-task cost), handgrip strength, lower-limb power (five-times sit-to-stand with linear encoder), gait speed, balance, muscle morphology of the vastus lateralis (ultrasound), cognition (Mini-Mental State Examination), and change in Vivifrail functional category. Data will be analyzed by intention to treat using generalized estimating equations (GEE), examining the group-by-time interaction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individualized multicomponent home-based training (strength/power, balance, gait, and flexibility) prescribed according to the participant's Vivifrail functional profile.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
Total SPPB score ranging from 0 to 12 points (higher scores indicate better lower-extremity physical function), combining balance, gait speed, and chair-stand tests.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
ime in seconds to rise, walk 3 meters, turn, return, and sit.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
TUG performed with a concurrent cognitive task; dual-task cost calculated as percentage change relative to single-task TUG.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
Maximal isometric handgrip strength in kilograms, measured with a Jamar dynamometer.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
ime in seconds and estimated lower-limb power measured during the five-times sit-to-stand test using a linear encoder.
Time frame: aseline (T0), 12 weeks (T1), and 24 weeks (T2)).
Usual gait speed in meters per second.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)).
Static balance assessed by the SPPB balance component (side-by-side, semi-tandem, and tandem stands).
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
Vastus lateralis muscle thickness measured by B-mode ultrasound, defined as the distance between the adipose-muscle and muscle-bone interfaces, analyzed in ImageJ by a single trained, blinded assessor.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
Muscle quality assessed by echo intensity on B-mode ultrasound, expressed in arbitrary units (grayscale, 0-255) via manual region-of-interest analysis in ImageJ, excluding fascia and bone. Higher echo intensity indicates greater intramuscular fat/fibrous infiltration, i.e., poorer muscle quality. Single assessor blinded to group allocation.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
Global cognitive function measured by the MMSE, using education-adjusted cutoffs.
Time frame: Baseline (T0), 12 weeks (T1), and 24 weeks (T2)
Transition across Vivifrail functional categories (Types A, B, B+, C, C+, D) over the intervention period.
Contact information is provided by the study sponsor or research team.
ALESSANDRA Silva QUADROS
CONTACT
Caroline Pietta Dias, PhD
CONTACT
Federal University of Rio Grande do Sul
Other
Effects of a Multicomponent Exercise Program Based on the Vivifrail Protocol on Functional Capacity, Muscle Morphology, and Cognition in Nonagenarians: A Randomized Clinical Trial
Acronym: Vivifrail
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05744167
Aging, Atrophy
Kaunas, Lithuania
View Trial DetailsNCT06968702
Aging, Behavior
View Trial DetailsNCT07669168
Activities of Daily Living, Aging
Boulder, Colorado, United States
View Trial DetailsNCT07646782
Activities of Daily Living, Aging
Boulder, Colorado, United States
View Trial Details